ArticleExperimental hematology & oncology2023

CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro.

Ming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.